PT UBC Medical Indonesia Tbk (IDX:LABS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
150.00
+1.00 (0.67%)
Apr 29, 2026, 9:09 AM WIB
Market Cap588.55B +30.7%
Revenue (ttm)199.30B +35.0%
Net Income13.51B +357.5%
EPS3.42 +357.5%
Shares Out3.95B
PE Ratio43.57
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,200
Average Volume855,075
Open150.00
Previous Close149.00
Day's Range149.00 - 150.00
52-Week Range113.00 - 166.00
Betan/a
RSI38.62
Earnings DateApr 24, 2026

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. The company operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. It offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. The company was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia. [Read more]

Sector Healthcare
Founded 2014
Employees 54
Stock Exchange Indonesia Stock Exchange
Ticker Symbol LABS
Full Company Profile

Financial Performance

In 2025, IDX:LABS's revenue was 199.30 billion, an increase of 34.99% compared to the previous year's 147.64 billion. Earnings were 13.51 billion, an increase of 357.50%.

Financial Statements